Showing results (1-10 of 41) with videos related to
Sort By:
Pageof 5
Clinics in Liver Disease|November 28, 2024
The Changing Demographics and Epidemiology of Hepatocellular CarcinomaRushabh Gujarathi, Jeremy A Klein, Chih-Yi Liao, et al.Frontiers in Oncology|September 13, 2024
Targeted therapies in hepatocellular carcinoma: past, present, and futureRushabh Gujarathi, Joseph W Franses, Anjana Pillai, et al.Surgical Pathology Clinics|February 4, 2023
Light It Up! The Use of DOTATATE in Diagnosis and Treatment of Neuroendocrine NeoplasmsJason L Schwarz, Jelani K Williams, Xavier M Keutgen, et al.Cancers|September 14, 2024
Peptide Receptor Radionuclide Therapy versus Capecitabine/Temozolomide for the Treatment of Metastatic Pancreatic Neuroendocrine TumorsRushabh Gujarathi, Joseph Tobias, Sara Abou Azar, et al.Cancer Medicine|April 13, 2026
Real World Outcomes With Chemotherapy and Immunotherapy in Metastatic Poorly Differentiated Gastroenteropancreatic Neuroendocrine CarcinomasRushabh Gujarathi, Samantha Kwock, Faith Abodunrin, et al.Journal of Vascular and Interventional Radiology : JVIR|December 15, 2022
Yttrium-90 Radioembolization and Concomitant Systemic Gemcitabine, Cisplatin, and Capecitabine as the First-Line Therapy for Locally Advanced Intrahepatic CholangiocarcinomaOsman Ahmed, Qian Yu, Mikin Patel, et al.Surgery|May 25, 2020
Response rates in metastatic neuroendocrine tumors receiving peptide receptor radionuclide therapy and implications for future treatment strategiesTanaz Vaghaiwalla, Brian Ruhle, Kelvin Memeh, et al.Surgery|October 10, 2025
Evaluating the role of postoperative long-acting somatostatin analog therapy in patients with metastatic neuroendocrine tumors undergoing surgical debulkingTheodoros Michelakos, Joseph Tobias, Sara Abou Azar, et al.Journal of Vascular and Interventional Radiology : JVIR|November 4, 2024
Survival Outcomes of Radiofrequency Ablation for Intrahepatic Cholangiocarcinoma from the Surveillance, Epidemiology, and End Results (SEER) Database: Comparison with Radiotherapy and ResectionQian Yu, Amar Mahbubani, Daniel Kwak, et al.Journal of Interventional Medicine|February 5, 2024
Combination of transarterial radioembolization with atezolizumab and bevacizumab for intermediate and advanced staged hepatocellular carcinoma: A preliminary report of safety and feasibilityQian Yu, Yating Wang, Ethan Ungchusri, et al.Pageof 5